Introduction
In chronic obstructive pulmonary disease (COPD) patients few modalities of airway clearance have demonstrated effectiveness in reducing hypersecretion and bronchial obstruction. Positive expiratory pressure (PEP) is one of these.
Objective
Our goal was to compare the effectiveness of 2 devices Temporary PEP (T-PEP) and Oscillatory PEP (O-PEP) which use PEP applied at a low expiratory pressure of 1 cm H2 O which creates oscillations that decrease bronchial obstruction in reducing COPD exacerbations and improving respiratory and health status assessment parameters. Each has different mechanism of action.
Methods
A 26 week randomized controlled study evaluated their efficacy in reducing exacerbations and improving health status assessment tests as well as respiratory function parameters in severe to very severe COPD patients. One hundred-twenty patients were enrolled: 40 patients received T-PEP therapy; 40 underwent treatment with O-PEP; 40 constituted the control group. The primary outcome was the reduction of exacerbations after 1, 3 and 6 months; secondary outcomes were improvement of lung function and health status assessment tests [Modified Medical Research Council (MMRC) scale, Breathlessness, Cough, and Sputum Scale (BCSS) scale, and COPD Assessment Test (CAT) score].
Results
Only T-PEP statistically reduced the exacerbations after 1 and 3 months compared to the control group. Both the 2 devices improved dyspnea scale (MMRC), lung function parameters, and health status assessment (CAT) tests compared to the control group. Both interventions were well-tolerated by our patients.
Conclusions
O-PEP and T-PEP are useful for COPD treatment but only T-PEP reduces exacerbations. Adding tools for airway clearance to medical therapy can help the management of COPD.
Nicolini A, Mascardi V, Grecchi B, Ferrari-Bravo M, Banfi P, Barlascini C.
Comparison of effectiveness of temporary positive expiratory pressure versus oscillatory
positive expiratory pressure in severe COPD patients.
Clin Respir J. 2018 Mar;12(3):1274-1282. doi: 10.1111/crj.12661. Epub 2017 Jul 16. PMID:
28665556.
Altre pubblicazioni in relazione con questo contenuto
Questo sito utilizza cookie tecnici e di profilazione.
Puoi accettare, rifiutare o personalizzare i cookie premendo i pulsanti desiderati.
Chiudendo questa informativa continuerai senza accettare.
Impostazioni privacy
Questo sito utilizza i cookie per migliorare la tua esperienza di navigazione su questo sito.
Visualizza la Cookie Policy
YouTube è un servizio di visualizzazione di contenuti video gestito da Google Ireland Limited e permette a questo Sito Web di integrare tali contenuti all’interno delle proprie pagine.
Questo widget è impostato in modo che YouTube non salvi informazioni e cookie inerenti agli Utenti su questo Sito Web, a meno che non riproducano il video.
Luogo del trattamento: Irlanda - Privacy Policy
Gravatar è un servizio di visualizzazione di immagini gestito da Automattic Inc. che permette a Automattic Inc. di integrare tali contenuti all’interno delle proprie pagine.
Luogo del trattamento: Stati Uniti - Privacy Policy

Dalle vie aeree superiori al polmone profondo, una soluzione completa per la gestione delle secrezioni e oltre.